Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Cyclacel Begins Phase 2 Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
January 13, 2009 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that the company has begun treating patients in a Phase 2, open...
Cyclacel Pharmaceuticals to Present At Two Upcoming Investor Conferences
November 13, 2008 13:34 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer, Spiro Rombotis,...
Cyclacel Pharmaceuticals to Present At Rodman & Renshaw 10th Annual Healthcare Conference
November 07, 2008 10:49 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC), (Nasdaq:CYCCP) announced today that its President and Chief Executive Officer, Spiro Rombotis,...
Cyclacel Pharmaceuticals Announces Third Quarter 2008 Financial Results
November 06, 2008 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today financial and operating results for the third quarter of 2008. The...
Cyclacel to Present At the Canaccord Adams Global Growth Conference
August 07, 2008 13:59 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 7, 2008 (PRIME NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today that Paul McBarron, Executive Vice President, Finance and COO, will...